RITEDOSE
LIVE

Serial Number

97124132

Owner

THE RITEDOSE CORPORATION

First Use Date

Jul 1, 2011

Filing Date

Nov 14, 2021

Add to watchlist:

No watchlists yet
View on USPTO

RITEDOSE Trademark

Serial Number: 97124132 • Registration: 7305546

RITEDOSE is a trademark filed by THE RITEDOSE CORPORATION on November 14, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). The application is currently registered and active.

Owner Contact Info

THE RITEDOSE CORPORATION (25 trademarks)

1 TECHNOLOGY CIRCLE
COLUMBIA, SC 29203

Entity Type: 03

Trademark Details

Filing Date

November 14, 2021

Registration Date

February 13, 2024

First Use Anywhere

July 1, 2011

First Use in Commerce

July 1, 2011

Published for Opposition

July 12, 2022

Goods & Services

Custom manufacture of pharmaceuticals to the order and specification of others. Repackaging services for others in the field of pharmaceuticals and other preparations for medical or veterinary purposes; Providing contract development and manufacturing organization (CDMO) services, namely, by providing contract manufacturing of pharmaceuticals for specific companies

Pharmaceutical oral liquid preparations for the treatment of colds, allergies, coughs, sinus ailments, fevers, gastrointestinal ailments, digestive ailments, cardiovascular ailments, circulatory ailments, blood anomalies, respiratory ailments, muscular-skeletal disorders, eye disorders, oral-ear-nose and throat problems, parasitic problems, endocrine problems, male and female sexual performance problems, reproductive system problems, urologic and urinary tract problems, hormone deficiencies, skin disorders, infections, neurological problems, insomnia, hair loss, immunologic ailments; Pharmaceutical oral liquid preparations in the nature of analgesics for pain management; Pharmaceutical oral liquid preparations in the nature of oral contraceptives; Blow fill seal containers for medical use sold filled with pharmaceutical oral liquid preparations for the treatment of colds, allergies, coughs, sinus ailments, fevers, gastrointestinal ailments, digestive ailments, cardiovascular ailments, circulatory ailments, blood anomalies, respiratory ailments, muscular-skeletal disorders, eye disorders, oral-ear-nose and throat problems, parasitic problems, endocrine problems, male and female sexual performance problems, reproductive system problems, urologic and urinary tract problems, hormone deficiencies, skin disorders, infections, neurological problems, insomnia, hair loss, immunologic ailments

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 1, 2025 ASCK
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 13, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 13, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 9, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 8, 2024 CNPR
EXAMINER'S AMENDMENT ENTERED
Jan 8, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 8, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 8, 2024 GNEA
SU-EXAMINER'S AMENDMENT WRITTEN
Jan 8, 2024 SNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 12, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 11, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 11, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 1, 2023 GNRN
NON-FINAL ACTION E-MAILED
Dec 1, 2023 GNRT
SU - NON-FINAL ACTION - WRITTEN
Dec 1, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 5, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 5, 2023 CRFA
ASSIGNED TO LIE
Nov 5, 2023 ALIE
NOTICE OF REVIVAL - E-MAILED
Nov 2, 2023 NREV
PETITION GRANTED - RESPONSE RECEIVED
Nov 2, 2023 PGRR
ASSIGNED TO PETITION STAFF
Oct 30, 2023 APET
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 14, 2023 TROA
TEAS PETITION TO REVIVE RECEIVED
Sep 14, 2023 PROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 8, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 8, 2023 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jun 8, 2023 CNRT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 10, 2023 EXRA
STATEMENT OF USE PROCESSING COMPLETE
May 9, 2023 SUPC
SOU EXTENSION 1 GRANTED
May 9, 2023 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 8, 2023 AITU
USE AMENDMENT FILED
Apr 18, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Apr 18, 2023 EISU
NOTICE OF REVIVAL - E-MAILED
Apr 18, 2023 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
Apr 18, 2023 TPEX
PETITION TO REVIVE-GRANTED
Apr 18, 2023 PETG
TEAS PETITION TO REVIVE RECEIVED
Apr 18, 2023 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 10, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 10, 2023 ABN6
SOU EXTENSION 1 FILED
Mar 6, 2023 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 6, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 12, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 12, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 22, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 3, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 24, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 23, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 23, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 13, 2022 GNRN
NON-FINAL ACTION E-MAILED
Apr 13, 2022 GNRT
NON-FINAL ACTION WRITTEN
Apr 13, 2022 CNRT
ASSIGNED TO EXAMINER
Apr 11, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 19, 2021 NWOS
NEW APPLICATION ENTERED
Nov 17, 2021 NWAP